Invention Grant
- Patent Title: TL1A antibodies and methods of treatment
-
Application No.: US17188025Application Date: 2021-03-01
-
Publication No.: US11767364B2Publication Date: 2023-09-26
- Inventor: Achal Mukundrao Pashine , Guodong Chen
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: BRISTOL-MYERS SQUIBB COMPANY
- Current Assignee: BRISTOL-MYERS SQUIBB COMPANY
- Current Assignee Address: US NJ Princeton
- The original application number of the division: US16097630
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; C07K16/24 ; A61K39/00
Abstract:
Disclosed are antibodies that bind specifically to the receptor TNF superfamily member 15 (TNFSF15), also known as TL1A. Methods of making and using the anti-TL1A antibodies are also described.
Public/Granted literature
- US20210188987A1 TL1A ANTIBODIES AND USES THEREOF Public/Granted day:2021-06-24
Information query
